Acadia Pharmaceuticals to Present at the Stifel 2020 Virtual Healthcare Conference on November 17, 2020
November 10 2020 - 9:00AM
Business Wire
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that
it will present at the Stifel 2020 Virtual Healthcare Conference on
Tuesday, November 17, 2020, at 3:20 p.m. Eastern Time.
The conference will be held virtually. A live webcast of
Acadia’s presentation will be accessible on the company’s website,
www.acadia-pharm.com, under the investors section and an archived
recording will be available on the website through December 15,
2020.
About Acadia Pharmaceuticals
Acadia is trailblazing breakthroughs in neuroscience to elevate
life through science. For more than 25 years we have been working
at the forefront of healthcare to bring vital solutions to people
who need them most. We developed and commercialized the first and
only approved therapy for hallucinations and delusions associated
with Parkinson’s disease psychosis. Our late-stage development
efforts are focused on dementia-related psychosis, negative
symptoms of schizophrenia and Rett syndrome, and in early-stage
clinical research we are exploring novel approaches to pain
management, and cognition and neuropsychiatric symptoms in central
nervous system disorders. For more information, visit us at
www.acadia-pharm.com and follow us on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201110005304/en/
Media Contact: Acadia Pharmaceuticals Inc. Eric Endicott (858)
914-7161 media@acadia-pharm.com
Investor Contact: Acadia Pharmaceuticals Inc. Mark Johnson, CFA
(858) 261-2771 ir@acadia-pharm.com
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Apr 2023 to Apr 2024